Please Wait
Applying Filters...
menu
    • menu
    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    An Enquiry

    Menu

    Adenine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 742Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Niagen Bioscience Premier Sponsor Of “NAD For Health' Conference
    Niagen Bioscience Premier Sponsor Of “NAD For Health' Conference

    09 Feb 2026

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2026-02-09/niagen-bioscience-is-the-premiere-sponsor-of-the-inaugural-nad-for-health-opportunities-challeng

    PHARMIWEB
    09 Feb 2026
    Share Share
    Niagen Bioscience To Release 2025 Financial Results On March 4,
    Niagen Bioscience To Release 2025 Financial Results On March 4,

    06 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260206144215/en/Niagen-Bioscience-to-Report-Fourth-Quarter-and-Full-Year-2025-Financial-Results-on-Wednesday-March-4-2026

    BUSINESSWIRE
    06 Feb 2026
    Share Share
    Abinopharm Releases AbinoNutra NMN Paper After FDA Approval
    Abinopharm Releases AbinoNutra NMN Paper After FDA Approval

    02 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/02/3230217/0/en/Abinopharm-Inc-Releases-AbinoNutra-NMN-White-Paper-Following-FDA-Reinstatement-and-Human-Clinical-Trial-Evidence.html

    GLOBENEWSWIRE
    02 Feb 2026
    Share Share
    Niagen Bioscience Expands HSA/FSA Access for Tru Niagen in US
    Niagen Bioscience Expands HSA/FSA Access for Tru Niagen in US

    15 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260115568615/en/Niagen-Bioscience-Expands-HSAFSA-Access-for-Tru-Niagen-the-Leading-NAD-Supplement-in-the-U.S.

    BUSINESSWIRE
    15 Jan 2026
    Share Share
    Cellular Energy Booster Reverses Advanced Alzheimer's In Mice
    Cellular Energy Booster Reverses Advanced Alzheimer's In Mice

    02 Jan 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/research/cellular-energy-booster-restores-cognition-mice-advanced-alzheimers-disease

    FIERCE BIOTECH
    02 Jan 2026
    Share Share
    Niagen Bio Acquires Patent Portfolio From Queen's University
    Niagen Bio Acquires Patent Portfolio From Queen's University

    22 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-22/niagen-bioscience-acquires-existing-core-nicotinamide-riboside-nr-patent-portfolio-from-queen-s-un

    PHARMIWEB
    22 Dec 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.